-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Deferred State and Local Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q3 2024.
- Integrated Biopharma Inc Deferred State and Local Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $54K, a 671% increase year-over-year.
- Integrated Biopharma Inc Deferred State and Local Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $48K.
- Integrated Biopharma Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2024 was $1K, a 94.4% decline from 2023.
Deferred State and Local Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred State and Local Income Tax Expense (Benefit), Quarterly (USD)
Deferred State and Local Income Tax Expense (Benefit), YoY Quarterly Growth (%)